Lack of alkaline phosphatase activity predicts meningioma recurrence

Corinne Bouvier1, Agnès Liprandi, Carole Colin

  • 1Department of Pathology, Faculty of Medicine, Timone Hospital, Marseille, France.

Insights

Reduced expression of tissue-type alkaline phosphatase (Pal) predicts meningioma recurrence. Histochemical detection of Pal is a simple, cost-effective method to identify tumors likely to return after surgery.

Area of Science:

  • Neurology
  • Oncology
  • Biochemistry

Background:

  • Meningiomas are typically benign intracranial tumors, but some exhibit aggressive behavior, including recurrence, invasion, and metastasis.
  • Reduced expression of tissue-type alkaline phosphatase (Pal) has been associated with high-grade meningiomas.

Purpose of the Study:

  • To investigate tissue-type alkaline phosphatase (Pal) expression as a predictor for meningioma recurrence.
  • To evaluate the utility of histoenzymology for assessing Pal expression in meningiomas.

Main Methods:

  • Studied Pal expression using histoenzymology in 54 meningiomas after gross total resection.
  • Correlated Pal expression with tumor grade, MIB-1 values, cytogenetic data, and recurrence status.

Main Results:

  • Pal expression was significantly altered in grades II and III meningiomas and those with high MIB-1 values.
  • Abnormal Pal expression strongly correlated with cytogenetic abnormalities and tumor recurrence (13/13 recurrent tumors showed abnormal Pal expression).
  • Pal expression was the sole significant predictor of recurrence-free survival in univariate analysis.

Conclusions:

  • Histochemical detection of Pal is a valuable, accessible, and economical method for predicting meningioma recurrence.
  • Assessing Pal expression can aid in identifying patients at higher risk for tumor recurrence.

Related Concept Videos